The document explains that pharmacovigilance teams must screen over 1.5 million publications yearly, even though most lack adverse event signals, making manual review slow and inefficient. Quantiphi’s Adverse Event Monitoring solution uses LLMs and a RAG workflow within its baioniq platform to filter literature, extract AE details, identify entities, and validate cases across multiple criteria. This accelerates detection and supports downstream reporting. Benefits shown on the page include an 80% reduction in drug alert setup time, 5x faster identification of reportable events, and 70% less workload for aggregate and safety signal reviews.

Join for free to read